Leveraging medtech to solve health care priorities
The needs of the health care system are changing rapidly, and so too are the technologies that exist to improve the accuracy and level of care medical practitioners require to make concise, life-saving diagnoses and treatments for patients in Atlantic Canada.
To further drive innovation in the medtech space, Volta, Nova Scotia Health Authority, BioNova, QEII Foundation, and the Atlantic Canada Opportunities Agency, have formed a strategic partnership to present the Health Challenge, a series of five pitch events focusing on specific health care priorities. Medtech companies participating in the competition will present their technologies that aim to solve various priorities pre-determined by the Nova Scotia Health Authority.
Tech companies in the medical realm with products and services already approved to sell in Canada must first apply to pitch at the competition via email to firstname.lastname@example.org. See below for submission guidelines. Then, select applicants will be invited to pitch during the Health Challenge Pitch Event at Volta to a panel of judges, comprised of leading industry experts. Members of the public are welcome to attend the events.
Presenters will have ten minutes to pitch their product or service, and then have five minutes to answer any questions from the judges. After each company has pitched their technology, judges will deliberate, and return to announce the winner.
The winner of the pitch event will receive $100,000, and their innovative technology will be considered for adoption by the Nova Scotia Health Authority.
The first Health Challenge Pitch Event will focus on cancer care.